← Eichor
Study identifier: NCT06203860 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Cardio-Metabolic Clinic

Condition: Diabetes Mellitus, Type 2 · Cardiovascular Diseases  ·  Sponsor: Odense University Hospital

PhaseNA
Planned participants1600
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to investigate whether a Cardio-Metabolic Clinic can protect the cardiovascular health of patients with both diabetes and cardiovascular disease. * At the Cardio-Metabolic Clinic, patients will receive a specialized and comprehensive care. This includes applying a systematic approach, considering their whole health based on the latest knowledge in the field, and administering aggressive treatment with heart protective medications. * The ProtecT-2-D trial will compare the effects of care at the Cardio-Metabolic Clinic to usual care to see if there are any differences in cardiovascular illness and death.

This description comes directly from the study's public registry record.

Talk to the study team

Soeren Auscher, M.D, Ph.D  ·  +45 6320 2402  ·  Soeren.Auscher@rsyd.dk

Katrine S. Overgaard, M.D  ·  +45 40949749  ·  katrine.schultz.overgaard@rsyd.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Cardiovascular Research Unit, Odense University Hospital - SvendborgSvendborg, Region Syddanmark, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06203860